Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Equity Ratio: 2013-2019

Historic Equity Ratio for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to 0.52.

  • Soleno Therapeutics' Equity Ratio rose 12.48% to 0.52 in Q3 2019 from the same period last year, while for Sep 2019 it was 0.52, marking a year-over-year increase of 12.48%. This contributed to the annual value of 0.70 for FY2018, which is 2.56% up from last year.
  • According to the latest figures from Q3 2019, Soleno Therapeutics' Equity Ratio is 0.52, which was up 27.77% from 0.41 recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Equity Ratio ranged from a high of 0.89 in Q1 2017 and a low of -1.12 during Q1 2015.
  • Its 3-year average for Equity Ratio is 0.65, with a median of 0.63 in 2018.
  • Per our database at Business Quant, Soleno Therapeutics' Equity Ratio soared by 488.08% in 2016 and then plummeted by 47.64% in 2018.
  • Soleno Therapeutics' Equity Ratio (Quarterly) stood at 0.39 in 2015, then spiked by 57.04% to 0.62 in 2016, then climbed by 11.33% to 0.69 in 2017, then grew by 2.56% to 0.70 in 2018, then rose by 12.48% to 0.52 in 2019.
  • Its last three reported values are 0.52 in Q3 2019, 0.41 for Q2 2019, and 0.61 during Q1 2019.